Which antiarrhythmic dose is used for pediatric VT after initial cardioversion if VT persists?

Prepare for the SNHD Paramedic Protocols Test. Utilize flashcards and multiple choice questions, with hints and explanations for each query. Ace your exam comfortably!

Multiple Choice

Which antiarrhythmic dose is used for pediatric VT after initial cardioversion if VT persists?

Explanation:
When a child’s ventricular tachycardia remains after cardioversion, the goal is to stabilize the rhythm with a fast-acting IV antiarrhythmic. Amiodarone is the preferred choice because it effectively suppresses a wide range of ventricular tachyarrhythmias and has a favorable safety profile in pediatric patients during the acute setting. The standard dose is 5 mg/kg given IV over about 20 minutes, diluted in 50 mL of normal saline. If the VT recurs or remains after the first dose, you can give another 5 mg/kg, up to a total of 15 mg/kg in 24 hours. Lidocaine can be used if amiodarone isn’t available, but it’s considered secondary because amiodarone generally provides broader control with a longer-lasting effect. Sotalol and procainamide are not first-line in this immediate post-cardioversion scenario due to risks such as QT prolongation and hypotension and are reserved for specific circumstances or longer-term management rather than acute stabilization.

When a child’s ventricular tachycardia remains after cardioversion, the goal is to stabilize the rhythm with a fast-acting IV antiarrhythmic. Amiodarone is the preferred choice because it effectively suppresses a wide range of ventricular tachyarrhythmias and has a favorable safety profile in pediatric patients during the acute setting. The standard dose is 5 mg/kg given IV over about 20 minutes, diluted in 50 mL of normal saline. If the VT recurs or remains after the first dose, you can give another 5 mg/kg, up to a total of 15 mg/kg in 24 hours.

Lidocaine can be used if amiodarone isn’t available, but it’s considered secondary because amiodarone generally provides broader control with a longer-lasting effect. Sotalol and procainamide are not first-line in this immediate post-cardioversion scenario due to risks such as QT prolongation and hypotension and are reserved for specific circumstances or longer-term management rather than acute stabilization.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy